جست‌وجوی استاد و پژوهشگر

Susan Landمشاهده پروفایل

دانشیار

• Genomics
• Cancer biology
• Next-generation sequencing
• +۴ مورد دیگر

Susan Land, PhD , is a full-time Associate Professor in Research at Wayne State University , where she also serves as Director of the Applied Genomics Technology Center (AGTC) . Spanning roles in research, teaching, and core-facility leadership, she supports investigators across the Department of Biology, the C. S. Mott Center for Human Growth and Development, and the Karmanos Cancer Institute. Education & Training: While specific degrees are not detailed in the provided text, Dr Land’s extensive instruction of graduate courses in genomics, cancer biology, and biomedical engineering indicates advanced graduate training in molecular biology or a closely related field. Research Interests: Dr Land’s work centers on genomic technologies , next-generation sequencing , single-cell genomics , and precision medicine . Her Applied Genomics Technology Center delivers DNA/RNA isolation, genotyping, expression profiling (qPCR, Illumina BeadArrays, Affymetrix GeneChips, digital gene expression), and whole-exome sequencing, supporting projects from cancer epidemiology to placental biology. Publication Trends: Across more than 60 peer-reviewed articles since 2002, her research demonstrates a clear trajectory from methodological tool development (e.g., SnpEff) to large-scale genetic epidemiology studies—particularly in lung and prostate cancer among African-American populations—and integrative systems-biology investigations of complex diseases such as preeclampsia and asthma pharmacogenomics. Scientific Awards & Honors: No specific awards are listed in the supplied text. Student Advising & Mentoring: Ahmed Ibrahim Ahmed, MD – PhD thesis on “Transcriptomic Analysis of Cell-Free RNA in the Amniotic Fluid of Patients with Preterm Labor using Next Generation Sequencing” Ongoing mentorship of MD/PhD students, Reproductive Endocrinology fellows, and junior faculty recruits via AGTC facility tours and collaborative projects. Laboratory & Core Facility: Dr Land directs the Applied Genomics Technology Center (AGTC) , a state-of-the-art Wayne State core facility equipped with low- and high-throughput genomic instrumentation. Services include DNA/RNA extraction, qPCR, Illumina BeadArrays, Affymetrix GeneChips, Illumina Genome Analyzer IIx, and comprehensive bioinformatics support.

Volker Kiesslingمشاهده پروفایل

دانشیار

• Membrane Biology
• Virology
• Biophysics
• +۳ مورد دیگر

Volker Kiessling is an Associate Professor in the Department of Molecular Physiology and Biological Physics at the University of Virginia School of Medicine. His research focuses on membrane fusion mechanisms in two key contexts: Secretory vesicle fusion with the plasma membrane Viral membrane fusion during infections like HIV and Ebola His work employs advanced techniques such as Planar supported membranes Single molecule tracking Fluorescence microscopy Cryo-electron microscopy to study the interplay between lipids and proteins during fusion processes. Key contributions include: Discovering the role of cholesterol in HIV fusion Elucidating synaptotagmin's mechanism in calcium-triggered exocytosis Identifying how lipid asymmetry affects fusion pore dynamics Characterizing viral entry requirements for Ebola and HIV His publications reveal a consistent focus on SNARE proteins, lipid domains, and viral entry mechanisms across multiple high-impact journals.

Georgios Mitsisمشاهده پروفایل

دانشیار

• Biomedical Engineering
• Neuroscience
• Signal Processing
• +۴ مورد دیگر

Georgios Mitsis is an Associate Professor and William Dawson Scholar at the Department of Bioengineering, McGill University . His research bridges signals and systems theory with life sciences, focusing on nonlinear/time-varying modeling of biological systems. Areas of expertise: Nonlinear and time-varying systems modeling Cerebral hemodynamics and autoregulation Time-varying functional brain connectivity Computational oncology Research trends : Recent publications highlight his work on dynamic functional connectivity in fMRI, cerebral autoregulation under physiological stress, and multiscale tumor growth modeling. Techniques include machine learning, Kalman filtering, and multimodal neuroimaging (EEG-fMRI, MEG). Scientific awards William Dawson Scholar Labs & teams : Leads the Biosignals and Systems Analysis Lab at McGill, collaborating with the Tumor Virology Lab at the University of Cyprus. Focuses on algorithm development for cerebral hemodynamics and cancer therapy optimization.

Rebecca Hoodمشاهده پروفایل

مدرس

• Neuroscience
• Cerebrospinal Fluid
• Hypoxia
• +۶ مورد دیگر

Dr. Rebecca Hood is an Honorary Associate Lecturer at the School of Biomedical Sciences and Pharmacy , University of Newcastle. Her research focuses on post-stroke recovery, particularly mechanisms underlying intracranial pressure elevation and secondary neurodegeneration after ischaemic stroke. She collaborates closely with Professor Rohan Walker and Professor Michael Nilsson in stroke research. Education : PhD in Human Physiology (University of Newcastle), BSc in Biomedical Sciences (Hons) (University of Newcastle) Her research interests span neuroscience , cerebrospinal fluid dynamics , hypoxia , intracranial pressure , and ischaemic stroke . Recent work explores secondary neurodegeneration in hippocampal regions post-stroke, antiplatelet drug effects on cognitive recovery, and novel therapies for cerebral edema and ICP reduction. Publications trend toward understanding the nexus of stroke and dementia, mechanisms of intracranial pressure elevation, and neurovascular impacts of drugs like clopidogrel. Her scientific awards include the Greaves Family Post-graduate Scholarship. She has secured grants from the Hunter Medical Research Institute (2022, $190,000) and the Agency for Clinical Innovation (2020, $169,000), among others. Her lab teams focus on stroke pathophysiology, virtual reality training systems (TACTICS VR), and translational neuroscience.

Pryank Patelمشاهده پروفایل

مدرس

• Structural Biology
• Protein Biochemistry
• Nuclear Receptors
• +۳ مورد دیگر

Pryank Patel is a Lecturer in Biochemistry at the University of Hertfordshire's School of Life and Medical Sciences within the Department of Clinical, Pharmaceutical and Biological Science. He joined the institution in 2013 and maintains active honorary positions as Research Fellow at Birkbeck College and Lecturer at the University of Liverpool. His educational background includes: PhD in Structural Biology from Birkbeck College (awarded February 15, 2008) MSc in Molecular Modelling & Bioinformatics from Birkbeck College (awarded September 1, 2001) BSc (Hons) in Biochemistry & Microbiology from Queen Mary University of London (awarded June 1, 2000) Prior experience includes 2.5 years as Scientific Programmer with CCP4 at Daresbury Laboratory and nearly 6 years as Postdoctoral Research Associate at the University of Liverpool. Dr. Patel's research centers on structural biology and protein biochemistry with emphasis on nuclear receptors (particularly thyroid hormone receptors), calcium-binding proteins, and their disease implications. His work integrates computational modeling, protein crystallography, and cell-based assays to investigate protein conformational changes, metastasis mechanisms, and drug-receptor interactions, with significant contributions to pancreatic cancer therapeutics and endocrine pharmacology. Analysis of his 2015-2020 publications reveals consistent focus on molecular disease mechanisms, particularly: 1) Structural characterization of protein switches (e.g., cysteine string protein phosphorylation), 2) Repurposing NSAIDs as nuclear receptor modulators, and 3) Developing anti-metastatic compounds targeting S100P in pancreatic cancer. His methodology bridges wet-lab experimentation with in silico modeling. No scientific awards were documented in the provided profile. While specific students and grants aren't listed, his collaborative publication record (including multi-institutional projects with Liverpool and industry partners) indicates active supervision and research funding. Current projects involve enhancing cellular stress tolerance using extremophile proteins and developing novel receptor antagonists. He operates within the Biosciences Research Group at the Centre for Research in Mechanisms of Disease and Drug Discovery, focusing on interdisciplinary approaches to disease mechanism elucidation and therapeutic development.

• Stem Cell Biology
• Regenerative Medicine
• Nitric Oxide Signaling
• +۴ مورد دیگر

Juan Rigoberto Tejedo Huaman is a Professor at the University of Pablo de Olavide within the Department of Molecular Biology and Biochemical Engineering. He serves as Faculty Member at the Center for Nanoscience and Sustainable Technologies (CNATS) and leads the META Research Group focused on Regeneration of the Pancreatic Beta Cell. His academic credentials include a PhD from the University of Seville with a thesis on the Role of cGMP-dependent protein kinase (PKG) and c-Src tyrosine kinase in the antagonistic regulation of nitric oxide on apoptosis. Dr. Tejedo's research spans multiple areas in molecular biology and regenerative medicine, with particular emphasis on nitric oxide signaling in stem cell biology, pancreatic beta cell regeneration , and diabetes therapeutics . His work has evolved from fundamental molecular mechanisms of nitric oxide in cell survival to clinical applications in regenerative medicine. He has made significant contributions to understanding how nitric oxide regulates stem cell differentiation, particularly in pancreatic development. Analysis of Dr. Tejedo's publication trends reveals a consistent focus on nitric oxide biology with expanding applications to regenerative medicine. His recent work (2022-2025) shows a strategic shift toward translational research, including cell therapy for diabetes complications, applications of mesenchymal stem cells for wound healing, and investigations into Long COVID treatments. His research bridges basic molecular mechanisms with clinical applications, particularly in diabetes and tissue regeneration. Dr. Tejedo has been involved in multiple doctoral programs including Biotechnology, Biomedicine and Health Sciences. His research has implications for several health conditions including diabetes, wound healing, and infectious diseases. His laboratory at CNATS focuses on stem cell differentiation protocols, particularly toward functional pancreatic beta cells, and investigates the molecular mechanisms behind nitric oxide's role in cell survival and differentiation.

• Islet Transplantation
• Type 1 Diabetes Mellitus
• Beta-cell Replacement
• +۴ مورد دیگر

Bernhard J Hering is a Professor in both the Department of Surgery and the Endocrine and Diabetes Division within the School of Medicine at the University of Minnesota. His primary research focus centers on islet transplantation and beta-cell replacement therapies for the treatment of type 1 diabetes. With an extensive publication record of 371 research outputs and leadership in 55 research projects and grants, Dr. Hering has established himself as a leading expert in diabetes research and transplantation medicine. Dr. Hering's research interests primarily focus on islet transplantation , beta-cell replacement therapies , and type 1 diabetes management . His work spans from basic science investigations of islet biology and immunology to clinical applications of islet transplantation. Key areas of investigation include developing methods for stem cell-derived islet replacement , optimizing islet cryopreservation techniques, understanding transplantation immunology , and improving outcomes for islet transplant recipients . His research has significant implications for patients with type 1 diabetes who experience severe hypoglycemia and other complications. Analysis of Dr. Hering's recent publications reveals a strong emphasis on advancing islet transplantation as a viable therapy for type 1 diabetes. His work spans multiple domains including clinical outcomes research using registry data, immunological studies to improve graft survival, engineering approaches to enhance islet quality and preservation, and investigations into the physiological responses of transplanted islets. The research demonstrates a progression from basic islet biology toward increasingly translational and clinical applications, with a particular focus on overcoming the immunological barriers to successful transplantation. Dr. Hering has received significant research funding from major organizations including the National Institutes of Health (NIH), BREAKTHROUGH T1D, and The Emmes Corporation. His current projects include: Growing Beta Cell Replacement in T1D by Tolerizing Stem Cell-Derived Islets (2025) REVEAL - Research Evaluating Vagal Excitation and Anatomical Linkages (2022-2025) Collaborative Islet Transplant Registry - Expert Site (2022-2027) Deep Immune Profiling of Nonchimeric Tolerance of Transplants in Nonhuman Primates (2022-2024) Engineering optimization and scaling enables high quality pancreatic islet cryopreservation for banking and transplant (2021-2025) Dr. Hering leads a multidisciplinary research team focused on advancing islet transplantation therapies. His laboratory collaborates extensively with researchers in immunology, biomedical engineering, endocrinology, and surgery. Current work centers on developing stem cell-derived islet replacement therapies, optimizing islet preservation techniques, and understanding the immune mechanisms that affect transplant outcomes. The team utilizes both preclinical models and clinical registry data to advance the field toward more effective and accessible treatments for type 1 diabetes.

Edward Avezovمشاهده پروفایل

استاد

• Neuroscience
• Cell Biology
• Dementia Research
• +۴ مورد دیگر

Edward Avezov serves as a Professor and Group Leader in the Department of Clinical Neurosciences at the University of Cambridge's School of Clinical Medicine. He is affiliated with the UK Dementia Research Institute and Cambridge Neuroscience, focusing on neuronal cell biophysics within the research themes of Neurons, Circuits and Networks, Beyond the Neuron, and Lifelong Brain Development and Brain Ageing. His research investigates endoplasmic reticulum (ER) structure-function relationships in neuronal physiology and dementia pathogenesis. Avezov's laboratory employs advanced techniques including super-resolution microscopy, genetically encoded biosensors, iPS cell models, and computational modeling to study organelle interactions, cellular neurophysiology, and protein homeostasis. Key clinical conditions under investigation include Alzheimer's disease, hereditary spastic paraplegia, and motor neurone disease. Analysis of Avezov's publication record reveals a consistent focus on ER dynamics in neurodegeneration. His work demonstrates how ER morphology regulation (e.g., via RTN4), luminal transport mechanisms, and stress responses contribute to neuronal dysfunction in dementia. Recent publications highlight innovative methodological developments like ERnet for quantitative ER topology analysis and discoveries regarding ER-mitochondria crosstalk, calcium signaling limitations, and stress-induced protein disaggregation. Avezov maintains active collaborations with leading Cambridge researchers including Michele Vendruscolo, Cahir O'Kane, John Skidmore, Clemens Kaminski, Gabriele Kaminski Schierle, David Rubinsztein, and David Klenerman. His laboratory actively participates in neuroscience community events such as NeuroBioUK and CellBio conferences, as evidenced by their social media presence.

Steven Owen Marxمشاهده پروفایل

استاد

• Molecular Biology
• Cardiovascular Research
• Ion Channels
• +۳ مورد دیگر

Steven Owen Marx, M.D., is a Professor of Medicine at Columbia University Vagelos College of Physicians and Surgeons, where he serves as Director of the Cardiovascular Fellowship Program at Columbia University Medical Center/NewYork-Presbyterian Hospital. He also directs the cardiology component of an NIH training grant for cardiology fellows and surgery residents. Education: B.S. in Biology, Union College M.D., Albany Medical College Postdoctoral Fellowship, Johns Hopkins Internship/Residency, University of Rochester-Strong Memorial Hospital Cardiology Fellowship/Clinical Electrophysiology Fellowship, Mount Sinai Medical Center Dr. Marx's research focuses on molecular cardiology and vascular biology, particularly the regulation of ion channels in cardiac and vascular tissues. His lab identified rapamycin (sirolimus) as a therapeutic agent for preventing restenosis after angioplasty/stent implantation and characterized ryanodine receptor dysfunction in heart failure. Current work emphasizes macromolecular complex formation in BKCa and L-type calcium channels, linking molecular mechanisms to systemic functions like blood pressure regulation. His recent publications highlight advances in adrenergic signaling, proximity proteomics, and genetically encoded tools for modulating ion channels. Articles span clinical trials (COAPT) and fundamental studies on calcium channel regulation. Scientific Awards: Westinghouse Science Talent Search Semi-Finalist (1982) Alpha Omega Alpha (AOA) (1988) American Heart Association Clinician-Scientist Award (1996–2001) Glorney-Raisbeck Fellowship (1996–1997) Dr. Marx leads NIH R01 and T32 grants and serves on peer review panels for NIH and AHA. His lab employs molecular biology and electrophysiology techniques to bridge fundamental discoveries with clinical applications in arrhythmias, heart failure, and hypertension.

• Veterinary Pharmacology
• Veterinary Toxicology
• Receptor Pharmacology
• +۴ مورد دیگر

Simone Bertini is a Full Professor in the Department of Veterinary Medical Sciences at the Faculty of Veterinary Medicine, University of Parma, Italy. Born in Pisa on August 10, 1968, he graduated in Veterinary Medicine from the University of Pisa in 1992 with honors (110/110 cum laude) and completed his PhD in Veterinary Environmental Pathology in 1997. His academic career progressed from Researcher in 1999, to Associate Professor in 2004, and finally to Full Professor in 2020. Prof. Bertini's research focuses on Veterinary Pharmacology and Toxicology, with particular emphasis on receptor pharmacology, drug kinetics, tissue residues of pharmaceuticals in veterinary species, and development of analytical methods in toxicology. His work spans experimental studies on gastric acid secretion modulation, bronchial and intestinal motility in horses, development of analytical techniques for drug residue detection, and environmental toxicology investigations including heavy metal and mycotoxin contamination in food chains. His publication record includes 146 scientific works comprising 65 international journal articles, 8 book chapters, 11 national journal articles, and numerous conference proceedings. Recent research has concentrated on environmental contaminants in wildlife and food products, oxidative stress biomarkers, and pharmacological interventions for respiratory and gastrointestinal conditions in animals. Prof. Bertini has held significant administrative roles including President of the Veterinary Medicine program (2018-2020), member of the University of Parma's Board of Directors (2021-2024), and participation in national committees related to veterinary drug evaluation and food safety. He has been actively involved in international collaborations through Erasmus+ teaching assignments in France and Spain.

• Bioactive (chromo)peptides from algae
• Protein-ligand interactions relevant for food systems
• Protein stability at high pressures
• +۱ مورد دیگر

Simeon L. Minic serves as an Assistant Professor in the Department of Biochemistry at the Faculty of Chemistry, University of Belgrade, having progressed through academic ranks from Researcher-intern (2017) to his current position since 2023. His career trajectory reflects dedicated service within the same institution, including roles as Research Associate (2018-2021) and Senior Research Associate (2022). Dr. Minic completed all academic training at the University of Belgrade - Faculty of Chemistry: Basic Academic Studies in Chemical Sciences (2008-2012), Master of Academic Studies (2012-2013), and Doctorate in Chemical Sciences (2013-2017). His educational foundation underpins his specialized research in bioactive compounds from algae and protein interactions. His research program centers on bioactive chromopeptides from algae , protein-ligand interactions in food systems , protein stability under high pressure , and development of cell culture media . These interconnected themes drive innovation in sustainable food technologies, particularly for algae-based colorants, nutraceuticals, and cultured meat applications. His work bridges fundamental biochemistry with practical food science challenges. Analysis of his 15 most recent publications (2015-2022) reveals consistent focus on phycobiliproteins from algae (particularly phycocyanobilin) and their interactions with dairy proteins (β-lactoglobulin, serum albumin, α-lactalbumin). The research combines multi-spectroscopic techniques , molecular dynamics simulations , and functional property assessment to address stability, binding mechanisms, and applications in food coloring, fortification, and health. Emerging trends show increasing emphasis on sustainable food systems, including microplastic toxicity and cultured meat media development. Dr. Minic's scientific recognition includes: First place in Montenegro's republican chemistry competition (2008) Đorđe Stefanović Diploma as top biochemistry student (2013) University of Belgrade Student Award (2013) Serbian Chemical Society Annual Award (2013) FEBS scholarships for international research (2015, 2022) He teaches core biochemistry courses including Regulation of Biochemical Processes, Enzymology, and Biochemistry of Food and Nutrition. As principal investigator, he leads four major international projects: IMPTOX (Horizon 2020 microplastics study), PRESSION (algae protein fortification using high pressure), ALG2MEAT (algae extracts for cultured meat), and Pep4Meat (algae chromopeptides as serum replacement). These projects, funded by the European Commission, ANSO, Good Food Institute, and Serbian Science Fund, demonstrate significant research leadership. His laboratory work operates within the Department of Biochemistry at Belgrade's Faculty of Chemistry, collaborating with international consortia. Dr. Minic actively contributes to the Serbian Chemical Society, Biochemical Society of Serbia, and Serbian Proteomics Association, maintaining strong professional networks in food biochemistry and protein science.

Murali Vijayanمشاهده پروفایل

عضو هیئت علمی

• Alzheimer's Disease
• Mitochondrial Biology
• MicroRNA Biology
• +۳ مورد دیگر

Murali Vijayan, Ph.D., is a Research Assistant Professor at the Texas Tech University Health Sciences Center within the Department of Internal Medicine . With expertise in mitochondrial biology , microRNA research , and genetics , his work focuses on Alzheimer's disease and other neurodegenerative conditions. He works under Dr. P. Hemachandra Reddy's mentorship and is affiliated with the Institute for One Health Innovation . Research Interests: Vijayan's research bridges molecular mechanisms with clinical applications, targeting: MicroRNA regulation in ischemic stroke and dementia Mitochondrial dysfunction in neurodegeneration Small molecule interventions for Alzheimer's disease Genetic risk factors for stroke and diabetes Mitophagy and synaptic protection Multi-omics approaches to neurological disorders Publication Trends: His 15 most recent articles (2014-2025) demonstrate consistent focus on Alzheimer's disease (8 papers), mitochondrial biology (11 papers), and microRNA regulation (7 papers). Key subfields include neurogenetics , transgenic disease models , and oxidative stress pathways . Scientific Recognition: Vijayan has received: 2024: Texas Alzheimer's Research and Care Consortium Junior Investigator Grant 2024: American Heart Association Career Development Award 2019: Employee of the Year for Research 2017: Best Oral Presentation Award for Stroke Biomarkers 2016: Newton International Fellowship 2012: FIMSA/IIS Travel Bursary 2010: Junior Research Fellowship Grants & Collaborations: His research has been supported by multiple grants, particularly focusing on Alzheimer's disease and mitochondrial dysfunction . He collaborates with institutions across Texas Tech University's health sciences network and works with interdisciplinary teams studying the intersection of metabolic disorders and neurological conditions.

Aditi Banerjeeمشاهده پروفایل

دانشیار

• Cancer Biology
• Endoplasmic Reticulum Stress
• Signal Transduction
• +۵ مورد دیگر

Dr. Aditi Banerjee is an Associate Professor in the Department of Pediatrics at the University of Maryland School of Medicine. Her research focuses on cancer biology, specifically targeting endoplasmic reticulum (ER) stress pathways and hypoxia-induced ischemia neuroprotection. She has developed innovative models using colon cancer spheroids and patient-derived organoids to study chemotherapeutic efficacy. Research Keywords: Unfolded Protein Response, Endoplasmic Reticulum Stress, Oncogene-Tumor Suppressor Signaling, and Molecular Mechanisms of Hypothermia. Scientific Contributions : First to identify FoxM1-RASSF1A signaling crosstalk in metastatic colon cancer Developed combinatorial therapies targeting ER stress pathways Collaborated with Dr. Jaylyn Waddell to study neonatal brain pathology Selected Awards : Travel Awards from ASBMB (2008, 2010) Best Poster Award, Pediatrics Research Day (2022) Advisory Board Member, Cellular and Molecular Life Sciences (2021)

• Transplantation
• Organ Preservation
• Biopreservation
• +۵ مورد دیگر

Timothy Pruett, MD is a Professor of Surgery and Internal Medicine at the University of Minnesota, specializing in the Division of Transplantation. His clinical and research work spans liver, kidney, and islet transplantation with expertise in organ preservation, biopreservation, and machine learning applications for improving transplant outcomes and allocation systems. His research addresses frailty assessment in transplant candidates using CT-derived body composition metrics, predictive modeling for liver disease progression (including the 'MELDPredict' tool), and ethical governance frameworks for emerging biopreservation technologies. He investigates immunosuppression minimization strategies, donor data analysis through AI, and the impact of sarcopenia on post-transplant recovery. Recent 2025 publications demonstrate heavy integration of artificial intelligence in transplantation medicine, featuring tools for donor allocation, biopreservation advancements, and policy analysis. Key themes include deep learning for sarcopenia assessment, ethical considerations in organ allocation, and HIV-related transplantation challenges, reflecting his dual focus on technological innovation and systemic policy reform. Dr. Pruett leads the multicenter Prospective Observational Study of TPIAT (POST) consortium and collaborates with interdisciplinary teams across surgery, internal medicine, and data science to enhance transplantation practices and patient quality of life.

Sung Mun Leeمشاهده پروفایل

دانشیار

• Biomedical Engineering
• Drug Delivery Systems
• Nanomedicine
• +۳ مورد دیگر

Dr. Sung Mun Lee is an Associate Professor at Khalifa University's Department of Biomedical Engineering. His work focuses on strategic design of drug delivery systems, development of novel biomaterials for nanomedicine, and targeting reactive oxygen species (ROS) in inflammatory diseases. Education: Ph.D. from Texas A&M University M.Sc. from Seoul National University B.S. from Korea University Research interests span ROS scavenging for diabetes and atherosclerosis, siRNA delivery to Kupffer cells in acute liver failure, nanoparticle engineering for protein protection, and targeted therapies for macrophages. His recent publications highlight interdisciplinary work in cancer therapy, oxidative stress diagnostics, organ-on-a-chip modeling, and bioprinting of functional tissues. Current projects include: Zein nanoparticles for oral therapeutic protein delivery Monocyte-based ROS scavenging systems for atherosclerosis Polyketal microparticles for siRNA delivery in acute liver failure Conductive MXene-gold bioinks for skeletal muscle engineering Dr. Lee teaches Biomedical Engineering Fundamentals (BMED351) and Biotransport Phenomena (BMED331) , and leads research groups at the Healthcare Engineering Innovation Group and Center for Biotechnology Research.